Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07398872 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of AAV9. hMCOLN1co For Patients With Mucolipidosis Type IV

Name: Safety and Efficacy of AAV9. hMCOLN1co For Patients With Mucolipidosis Type IV — clinical trial record (NCT07398872)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AAV9-hMCOLN1

StatusEnrolling by Invitation

PhasePhase 1

SponsorThe Children's Hospital of Zhejiang University School of Medicine

Started2026-01-13

View on ClinicalTrials.gov ↗

The Children's Hospital of Zhejiang University School of Medicine

58 trials monitored

See all monitored trials

Safety and Efficacy of AAV9.hMCOLN1co for patients with Mucolipidosis Type IV(MLIV): A Single-Center, Interventional, Open-Label, Single-Arm Clinical Study. The goal of this clinical trial is to evaluate whether a gene therapy can safely treat children with MLIV.

Trial Details

NCT Number	NCT07398872
Lead Sponsor	The Children's Hospital of Zhejiang University School of Medicine
Conditions	Mucolipidosis Type IV
Enrollment	1 participants
Start Date	2026-01-13
Primary Completion	2027-01-20 (estimated)
Study Completion	2031-01-20 (estimated)
Updated on ClinicalTrials.gov	2026-02-10